2016 annual financial data
Celldex Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,665.72%.
Operating income was -132,916,000 USD and net income was -128,530,000 USD.
Operating cash flow was -113,036,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,786,000 USD
- Operating income
- -132,916,000 USD
- Net income
- -128,530,000 USD
- Operating cash flow
- -113,036,000 USD